Evidence map›Paper›PMID 41878778›Full record

ReviewFEBS letters2026

Chemical biology approaches to study and target circadian clocks and their components.

Emmanuel F Rivera-Iglesias, Mohamed A Elanany, Michelle E Farkas

Abstract readReview
In one paragraph

Review in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmanuel F Rivera-IglesiasDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA, USA.ORCID https://orcid.org/0009-0009-8456-6557
Mohamed A ElananyDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA, USA.ORCID https://orcid.org/0000-0002-1784-8572
Michelle E FarkasDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA, USA.ORCID https://orcid.org/0000-0001-5824-1243

Funding

Chemistry-Biology Interface Predoctoral Training GrantT32GM139789 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ERIC Robert STRIETER · 2021 to 2026
$3.4M
Chemical Biology Approaches for Studying Circadian RhythmsR35GM143016 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FARKAS, MICHELLE ELIZABETH · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM143016NIGMS NIH HHS T32 GM139789
6 · The paper itself

Abstract

Circadian rhythms are biological cycles of approximately 24 h that align physiology and behavior with the solar day, helping organisms coordinate their functions with the light/dark cycle. These rhythms are generated by molecular circadian clocks found in cells that are composed of transcription/translation negative feedback loops and regulate gene activity and protein production. The field of chemical biology has generated tools to track, modify, and manipulate clock proteins in living systems, providing a meaningful way to study these clocks and their components. Small molecules, covalent tags, and detectable reporters, among others, have been used to reveal how clocks keep time, respond to environmental signals, and differ across organisms. In this review, we highlight and describe chemical biology approaches used to study and modulate molecular circadian mechanisms that have expanded understanding of circadian protein dynamics and interactions in the contexts of mammalian and Drosophila models. The application of chemical biology strategies to study and target circadian clocks and their components can expand our fundamental knowledge via means that are otherwise inaccessible and point toward new strategies for treating clock-related disorders.

Indexed as

Circadian ClocksCLOCK ProteinsAnimalsCircadian RhythmHumansCLOCK Proteinsclock proteinsgenetic code expansionhigh‐throughput screeningproximity labelingreportersself‐labeling protein tagssmall molecule circadian modulators

Identifiers

PMID41878778
PMCPMC13339984

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.